In this free webinar, gain insights into addressing challenges to operationalizing a gene therapy trial such as manufacturing, patient recruitment, site selection and activation, and regulatory considerations. The featured speakers will share insights into incorporating feedback from patient advocacy groups and regulatory agency consultancy into trial design. They will also discuss the importance of long-term follow-up in rare disease gene therapy studies and the need to consider optimized digital capabilities.
TORONTO, June 29, 2023 /PRNewswire-PRWeb/ -- In a rapidly advancing field of medical science, understanding the complexities of gene therapy trials in the context of rare diseases is of paramount importance. To shed light on this significant topic, the PPD clinical research business of Thermo Fisher Scientific is collaborating with Xtalks to host a free webinar about the evolving landscape of gene therapy research, particularly focusing on rare diseases.
The webinar will explore the key obstacles in the path of gene therapy trials, including accessing global patient populations, site training and activation, manufacturing and regulatory considerations, and the lack of standardization in data platforms. It also will shed light on the importance of incorporating patient feedback into protocol design, recognizing it as a critical step in advancing these therapies.
The webinar will be led by esteemed industry professionals from the PPD clinical research business of Thermo Fisher Scientific: Dr. Meagan Spychala, executive director of project management, with nearly 20 years of experience in the clinical research industry; Dr. Kim Watanabe, executive director of cell and gene therapy, who has 20 years of experience in R&D, business and operations, with the last 14 years focused on cell and gene therapies; and Dr. Panteli Theocharous, global vice president, cell and gene therapy strategy lead, who is a cancer immunotherapy expert and a senior-level industry executive in prior CMO roles.
PPD clinical research services enable Thermo Fisher Scientific customers to drive innovation and increase drug development productivity. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, the PPD business serves pharma, biotech, medical device and government organizations with custom-tailored solutions.
The live webinar, "Rare Disease Trials and Gene Therapy: Understanding the Patient Journey," is scheduled for Tuesday, July 18, 2023, at 10 a.m. EDT (4 p.m. CEST/EU-Central). It promises to be an enlightening and educational event, providing unique perspectives on the patient journey in gene therapy trials for rare diseases.
For more information, or to register for this event, visit Rare Disease Trials and Gene Therapy: Understanding the Patient Journey.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
Share this article